Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed Tomography
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Endoscopic ultrasonography (EUS) provides high-resolution images and is superior to computed tomography (CT) scan in diagnosing small pancreatic ductal adenocarcinoma (PDAC). As a result, the use of EUS for early detection of PDAC has attracted attention. This study aimed to identify the clinical and radiological characteristics of patients with PDAC diagnosed by EUS but not found on CT scan. Methods: The medical records of patients diagnosed with PDAC at 12 tertiary referral centers in Korea from January 2003 to April 2019 were reviewed. This study included patients with pancreatic masses not clearly observed on CT scan but identified on EUS. The clinical characteristics and radiological features of the patients were analyzed, and survival analysis was performed. Results: A total of 83 patients were enrolled. The most common abnormal CT findings other than a definite mass was pancreatic duct dilatation, which was identified in 61 patients (73.5%). All but four patients underwent surgery. The final pathologic stages were as follows: IA (n=31, 39.2%), IB (n=8, 10.1%), IIA (n=20, 25.3%), IIB (n=17, 21.5%), III (n=2, 2.5%), and IV (n=1, 1.4%). The 5-year survival rate of these patients was 50.6% (95% confidence interval, 38.8% to 66.7%). Elevated liver function testing and R1 resection emerged as significant predictors of mortality in the multivariable Cox regression analysis. Conclusions: This multicenter study demonstrated favorable long-term prognosis in patients with PDAC diagnosed by EUS but indeterminate on CT scan. EUS should be considered for patients with suspected PDAC but indeterminate on CT scan.
Abstract
Background/Aims: Endoscopic ultrasonography (EUS) provides high-resolution images and is superior to computed tomography (CT) scan in diagnosing small pancreatic ductal adenocarcinoma (PDAC). As a result, the use of EUS for early detection of PDAC has attracted attention. This study aimed to identify the clinical and radiological characteristics of patients with PDAC diagnosed by EUS but not found on CT scan. Methods: The medical records of patients diagnosed with PDAC at 12 tertiary referral centers in Korea from January 2003 to April 2019 were reviewed. This study included patients with pancreatic masses not clearly observed on CT scan but identified on EUS. The clinical characteristics and radiological features of the patients were analyzed, and survival analysis was performed. Results: A total of 83 patients were enrolled. The most common abnormal CT findings other than a definite mass was pancreatic duct dilatation, which was identified in 61 patients (73.5%). All but four patients underwent surgery. The final pathologic stages were as follows: IA (n=31, 39.2%), IB (n=8, 10.1%), IIA (n=20, 25.3%), IIB (n=17, 21.5%), III (n=2, 2.5%), and IV (n=1, 1.4%). The 5-year survival rate of these patients was 50.6% (95% confidence interval, 38.8% to 66.7%). Elevated liver function testing and R1 resection emerged as significant predictors of mortality in the multivariable Cox regression analysis. Conclusions: This multicenter study demonstrated favorable long-term prognosis in patients with PDAC diagnosed by EUS but indeterminate on CT scan. EUS should be considered for patients with suspected PDAC but indeterminate on CT scan.
참고문헌 (31)
- "Cancer stat facts: pancreatic cancer, cancer statistics"[URL]
- Hart PA, "Early detection of pancreatic cancer in high-risk individuals : where do we go from here?", Am J Gastroenterol, 114, pp.560~561 (2019)
- Wray CJ, "Surgery for pancreatic cancer : recent controversies and current practice", Gastroenterology, 128, pp.1626~1641 (2005)
- Hanada K, "Diagnostic strategies for early pancreatic cancer", J Gastroenterol, 50, pp.147~154 (2015)
- Kitano M, "Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer", J Gastroenterol, 54, pp.19~32 (2019)
- Edge SB, "The American Joint Committee on Cancer : the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Müller MF, "Pancreatic tumors : evaluation with endoscopic US, CT, and MR imaging", Radiology, 190, pp.745~751 (1994)
- Lee ES, "Imaging diagnosis of pancreatic cancer : a state-of-the-art review", World J Gastroenterol, 20, pp.7864~7877 (2014)
- Pietryga JA, "Imaging preoperatively for pancreatic adenocarcinoma", J Gastrointest Oncol, 6, pp.343~357 (2015)
- "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Pancreatic adenocarcinoma version2.2019" (2019)[URL]
- Prokesch RW, "Isoattenuating pancreatic adenocarcinoma at multi-detector row CT : secondary signs", Radiology, 224, pp.764~768 (2002)
- Yoon SH, "Small(≤ 20 mm)pancreatic adenocarcinomas : analysis of enhancement patterns and secondary signs with multiphasic multidetector CT", Radiology, 259, pp.442~452 (2011)
- Sakamoto H, "Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas", Ultrasound Med Biol, 34, pp.525~532 (2008)
- Klapman JB, "Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer", Am J Gastroenterol, 100, pp.2658~2661 (2005)
- Yamaguchi K, "Clinical Practice Guidelines for Pancreatic Cancer 2016 from the Japan Pancreas Society : a synopsis", Pancreas, 46, pp.595~604 (2017)
- Deerenberg EB, "Role of endoscopic ultrasonography in patients suspected of pancreatic cancer with negative helical MDCT scan", Dig Surg, 28, pp.398~403 (2011)
- Meijer OL, "Endoscopic ultrasonography in suspected pancreatic malignancy and indecisive CT", Neth J Med, 68, pp.360~364 (2010)
- Wang W, "Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT", Gastrointest Endosc, 78, pp.73~80 (2013)
- Srisajjakul S, "CT and MR features that can help to differentiate between focal chronic pancreatitis and pancreatic cancer", Radiol Med, 125, pp.356~364 (2020)
- Tanaka S, "Main pancreatic duct dilatation : a sign of high risk for pancreatic cancer", Jpn J Clin Oncol, 32, pp.407~411 (2002)
- Tanaka S, "Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer : a prospective study", Radiology, 254, pp.965~972 (2010)
- Fujisawa T, "Prevalence rate and predictive factors of pancreatic diseases in cases with pancreatic duct dilatation : a cross-sectional study of a large, healthy Japanese population", Intern Med, 59, pp.769~777 (2020)
- Yamamoto Y, "The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer", Anticancer Res, 34, pp.2389~2394 (2014)
- Pawlik TM, "Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer", Surgery, 141, pp.610~618 (2007)
- Rau BM, "R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use", Surgery, 152(3 Suppl 1), pp.S103~S111 (2012)
- Darnell EP, "Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer", Am J Surg, 221, pp.134~140 (2021)
- Decker C, "Biliary metal stents are superior to plastic stents for preoperative biliary decompression in pancreatic cancer", Surg Endosc, 25, pp.2364~2367 (2011)
- Geneletti S, "Adjusting for selection bias in retrospective, case-control studies", Biostatistics, 10, pp.17~31 (2009)
- Monnin P, "Optimal slice thickness for object detection with longitudinal partial volume effects in computed tomography", J Appl Clin Med Phys, 18, pp.251~259 (2017)
- Hewitt MJ, "EUS-guided FNA for diagnosis of solid pancreatic neoplasms : a meta-analysis", Gastrointest Endosc, 75, pp.319~331 (2012)
- Bhutani MS, "The no endosonographic detection of tumor(NEST)study : a case series of pancreatic cancers missed on endoscopic ultrasonography", Endoscopy, 36, pp.385~389 (2004)